EAM
SGNT

EverPoint Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

EverPoint Asset Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-900,000
Closed -$11M – 578
2016
Q1 		$11M Sell
900,000
-500,000
-36% -$7.01M 0.22% 123
2015
Q4 		$22.3M Buy
1,400,000
+350,000
+33% +$5.51M 0.47% 53
2015
Q3 		$16.1M Buy
+1,050,000
New +$22.7M 0.42% 55

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's SGNT Position: Q2 2016 in Review

EverPoint Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 900,000 shares — an estimated $11M sold.

EverPoint Asset Management first reported a position in SGNT in Q3 2015 and held it in 3 quarters. The position peaked at $22.3M in Q4 2015. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • EverPoint Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 900,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $11M.
  • EverPoint Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2015 and held it in 3 quarters.
  • EverPoint Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $22.3M in Q4 2015.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on EverPoint Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.